LAVORINI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.006
EU - Europa 7.194
AS - Asia 2.324
SA - Sud America 293
OC - Oceania 100
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.983
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.955
PL - Polonia 2.934
RU - Federazione Russa 1.858
HK - Hong Kong 769
IT - Italia 687
SG - Singapore 640
IE - Irlanda 602
CN - Cina 410
SE - Svezia 323
BR - Brasile 267
DE - Germania 180
GB - Regno Unito 136
FI - Finlandia 135
IN - India 127
VN - Vietnam 111
UA - Ucraina 108
AU - Australia 97
ID - Indonesia 84
JO - Giordania 76
FR - Francia 64
NL - Olanda 47
CH - Svizzera 44
CI - Costa d'Avorio 41
CA - Canada 30
ES - Italia 24
TR - Turchia 23
BE - Belgio 13
CZ - Repubblica Ceca 10
IQ - Iraq 10
MX - Messico 10
AR - Argentina 9
BD - Bangladesh 8
JP - Giappone 8
MA - Marocco 7
RO - Romania 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
PK - Pakistan 6
SC - Seychelles 6
VE - Venezuela 6
IL - Israele 5
KR - Corea 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
EC - Ecuador 4
AL - Albania 3
AT - Austria 3
BG - Bulgaria 3
CL - Cile 3
IR - Iran 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
CO - Colombia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JM - Giamaica 2
KZ - Kazakistan 2
MM - Myanmar 2
MU - Mauritius 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PA - Panama 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 18.983
Salva come PNG Salva come JPEG
Città #
Warsaw 2.931
Santa Clara 2.521
Fairfield 1.031
Hong Kong 635
Dublin 595
Ashburn 534
Woodbridge 444
Chandler 412
Seattle 411
Singapore 399
Cambridge 390
Houston 368
Wilmington 334
Altamura 178
Ann Arbor 177
Lawrence 170
Princeton 162
Jacksonville 143
Florence 126
Boston 116
Moscow 115
Beijing 108
Melbourne 94
Dong Ket 90
Jakarta 82
Mumbai 82
San Diego 78
Milan 66
Munich 63
Medford 62
Shanghai 62
Boardman 59
Buffalo 59
Hefei 56
Bern 44
Abidjan 41
Falls Church 37
Norwalk 36
Kent 30
The Dalles 30
Phoenix 28
Los Angeles 27
New York 25
London 24
Helsinki 23
Barcelona 22
Manchester 22
São Paulo 22
Turku 22
Bengaluru 21
Washington 21
Yubileyny 21
Paris 19
Hillsboro 18
Toronto 18
Amsterdam 16
Frankfurt am Main 16
Lappeenranta 16
Guangzhou 15
Izmir 13
Brussels 12
West Jordan 12
Rome 11
Andover 10
Nanjing 10
Düsseldorf 9
Lauterbourg 9
Pune 9
Siena 9
Bari 8
Redwood City 8
San Francisco 8
Chicago 7
Messina 7
Prague 7
Tashkent 7
Beauharnois 6
Belo Horizonte 6
Glasgow 6
Modena 6
Portsmouth 6
Shenzhen 6
Tokyo 6
Campinas 5
Charlotte 5
Curitiba 5
Mexico City 5
Rio de Janeiro 5
Romola 5
Salerno 5
Seoul 5
Southwark 5
Tel Aviv 5
Auburn Hills 4
Baku 4
Bexley 4
Brasília 4
Brooklyn 4
Cagliari 4
Dearborn 4
Totale 14.043
Salva come PNG Salva come JPEG
Nome #
Antitussive effect of carcainium chloride in patients with chronic cough and idiopathic interstitial pneumonias: A pilot study 304
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD 263
Effect of an anti-reflux medical device in the control of deflation cough: A placebo-controlled comparative study with an antacid drug in chronic coughers 259
A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic Cough. 258
Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD 257
Pulmonary hypertension nosography: are all patients classifiable? 252
Cough and ventilatory adjustments evoked by aerosolised capsaicin and distilled water (fog) in man 240
Inhaler technique: Facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT) 232
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. 231
A 57-year-old chronic cougher with somatically evoked cough. 230
Gorham-Stout Disease Management during Pregnancy 230
Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy 209
Recent advances in capsule-based dry powder inhaler technology 207
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis 206
Increased Risk of Atherosclerosis in Patients with Sarcoidosis 195
Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study 192
Critical inhaler errors in asthma and COPD: A systematic review of impact on health outcomes 186
Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here? 184
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 173
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting 172
Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease 166
Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: The Easy Low Instruction Over Time (ELIOT) study 165
Desensitization of the cough reflex by exercise and voluntary isocapnic hyperpnea 159
100 Years of Drug Delivery to the Lungs 158
Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD. 154
The lung microbiome: clinical and therapeutic implications 153
A multinational observational study identifying primary care patients at risk of overestimation of asthma control 153
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 152
Fog-induced Cough With Impaired Respiratory Sensation in Congenital Central Hypoventilation Syndrome. 152
A noninvasive electromyographic study on threshold and intensity of cough in humans. 151
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 148
Inhaler technique mastery and maintenance in healthcare professionals trained on different devices 148
Different respiratory behaviors disclosed by induced bronchoconstriction in mild asthma patients. 143
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 142
Handgrip-induced airway dilation in asthmatic patients with bronchoconstriction induced by MCh inhalation. 140
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes 138
The ADMIT series – Issues in Inhalation Therapy. 5) Inhaler selection in children with asthma 136
Validation of a method to assess emphysema severity by spirometry in the COPDGene study. 134
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 133
The demographic and clinical characteristics of an Italian population of adult outpatients with chronic cough 133
Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2 132
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. 130
Desensitization of the cough reflex by exercise and voluntary isocapnic hyperpnea 129
Respiratory rate assessments using a dual-accelerometer device 128
Retail sales of inhalation devices in European countries: So much for a global policy 128
Breathing pattern during fog challenges in humans 127
EP1.04-02 Predictors of Lung Toxicity in First Line Pembrolizumb for Advanced NSCLC: An Interim Analysis of PRELUTOX Study 127
Respiratory expulsive efforts evoked by maximal lung emptying. 124
The Clinical Value of Deflation Cough in Chronic Coughers with Reflux Symptoms 122
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: A retrospective matched observational study of real-world patients 122
The challenge of delivering therapeutic aerosols to asthma patients 121
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab 121
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape 119
Defective motor control of coughing in Parkinson's disease. 118
Inhaler technique and patient's preference for dry powder inhaler devices 117
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 117
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes 116
Fog-induced respiratory responses are attenuated by nedocromil sodium in humans 116
Coughing in laryngectomized patients. 116
Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes 116
Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: A randomised, crossover, open-label study 116
Voluntary and reflex cough: Similarities and differences 115
The Fontana paradoxical reflex? 114
Repeatability of cough-related variables during fog challenges at threshold and suprathreshold stimulus intensity in humans. 113
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab 113
Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices 112
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 112
Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series 111
The fi rst tissue-engineered airway transplantation: 5-year follow-up results 111
A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers 111
Diagnostic strategies for suspected pulmonary embolism 110
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: Impact on patient outcome 110
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 110
Prostaglandin synthesis blockade by ketoprofen attenuates respiratory and cardiovascular responses to static handgrip. 109
Correct inhalation technique is critical in achieving good asthma control 108
Agreement between two methods fr assessing bioequivalence of inhaled salbutamol. 106
Dilemmas, Confusion, and Misconceptions Related to Small Airways Directed Therapy 106
Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study 105
Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction 104
Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism. 104
Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients 104
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 104
Targeting drugs to the airways: the role of spacer devices 103
The ADMIT series--issues in inhalation therapy. 2. Improving technique and clinical effectiveness 102
Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases 101
The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD. 99
Switching treatments in COPD: Implications for costs and treatment adherence 99
Patients’ perspectives and preferences in the choice of inhalers: The case for Respimat® or HandiHaler® 99
Prevalence of nutritional risk and malnutrition during and after hospitalization for COVID-19 infection: Preliminary results of a single-centre experience 99
ADMIT Working Group. Inhaler choice and inhalation technique: key factors for asthma control. 98
What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis 98
Classification of COPD patients by using a standardised diagnostic questionnaire 97
Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study 97
Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center 97
Airway response to fenoterol hydrobromide and oxitropium bromide alone or in sequence in stable COPD patients 96
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients 95
Classification of COPD patients by using standardised diagnostic procedures 94
Cough in children with congenital central hypoventilation syndrome. 94
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD 93
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study 92
Totale 14.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.414 181 276 86 283 119 285 148 211 189 400 76 160
2021/20221.091 51 94 84 32 39 97 37 83 64 62 125 323
2022/20232.380 273 458 76 158 142 407 354 119 220 44 61 68
2023/20241.081 38 131 197 90 90 128 42 149 16 98 62 40
2024/20257.476 251 733 451 1.034 2.236 990 185 449 328 199 283 337
2025/2026143 143 0 0 0 0 0 0 0 0 0 0 0
Totale 19.203